Dennis Colussi

1.6k total citations
44 papers, 827 citations indexed

About

Dennis Colussi is a scholar working on Molecular Biology, Hematology and Physiology. According to data from OpenAlex, Dennis Colussi has authored 44 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Hematology and 11 papers in Physiology. Recurrent topics in Dennis Colussi's work include Blood Coagulation and Thrombosis Mechanisms (16 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Dennis Colussi is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (16 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Dennis Colussi collaborates with scholars based in United States, Switzerland and Algeria. Dennis Colussi's co-authors include Mark H. Perrone, Linda Merkel, Karen Brown, Valeria Chu, Joseph P. Vacca, Shi‐Shan Mao, Samuel Graham, Steven S. Carroll, Robert J. Leadley and Sanjeev Munshi and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Dennis Colussi

42 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dennis Colussi United States 20 328 236 214 142 140 44 827
Babu Subramanyam United States 15 351 1.1× 130 0.6× 42 0.2× 49 0.3× 179 1.3× 35 1.0k
Ola Fjellström Sweden 20 550 1.7× 85 0.4× 83 0.4× 43 0.3× 86 0.6× 40 854
Massimo Bertinaria Italy 20 644 2.0× 311 1.3× 36 0.2× 137 1.0× 38 0.3× 54 1.2k
Irena Melnikova United States 13 367 1.1× 107 0.5× 117 0.5× 180 1.3× 50 0.4× 22 919
Robert J. Ife United Kingdom 23 865 2.6× 417 1.8× 83 0.4× 94 0.7× 32 0.2× 52 1.7k
Friederike Stoll Germany 9 274 0.8× 66 0.3× 130 0.6× 112 0.8× 25 0.2× 20 531
Michael Szelke United Kingdom 20 764 2.3× 237 1.0× 79 0.4× 55 0.4× 28 0.2× 62 1.3k
John P. Umland United States 14 509 1.6× 144 0.6× 86 0.4× 94 0.7× 17 0.1× 17 1.2k
Emanuele Amata Italy 27 1.0k 3.2× 393 1.7× 175 0.8× 68 0.5× 35 0.3× 75 1.6k
Joseph B. Santella United States 11 312 1.0× 567 2.4× 75 0.4× 55 0.4× 19 0.1× 19 901

Countries citing papers authored by Dennis Colussi

Since Specialization
Citations

This map shows the geographic impact of Dennis Colussi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Colussi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Colussi more than expected).

Fields of papers citing papers by Dennis Colussi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Colussi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Colussi. The network helps show where Dennis Colussi may publish in the future.

Co-authorship network of co-authors of Dennis Colussi

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Colussi. A scholar is included among the top collaborators of Dennis Colussi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Colussi. Dennis Colussi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffman, Charles S., Dennis Colussi, John Gordon, et al.. (2024). First Demonstration of In Vivo PDE11A4 Target Engagement for Potential Treatment of Age-Related Memory Disorders. Journal of Medicinal Chemistry. 67(19). 17774–17784. 1 indexed citations
2.
Ly, Judy, Charles S. Hoffman, Michy P. Kelly, et al.. (2023). First Optimization of Novel, Potent, Selective PDE11A4 Inhibitors for Age-Related Cognitive Decline. Journal of Medicinal Chemistry. 66(21). 14597–14608. 4 indexed citations
3.
Rico, Mario C., Óscar Cano Pérez, Mary F. Barbe, et al.. (2023). Extracellular Acetylated Histone 3.3 Induces Inflammation and Lung Tissue Damage. Biomolecules. 13(9). 1334–1334. 3 indexed citations
4.
Blass, Benjamin E., et al.. (2021). Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening. Journal of Chemical Information and Modeling. 61(2). 1020–1032. 31 indexed citations
5.
Srinivasulu, Vunnam, Mohamad Hamad, Hamadeh Tarazi, et al.. (2021). Discovery of Novel Small-Molecule Inhibitors of SARS-CoV-2 Main Protease as Potential Leads for COVID-19 Treatment. Journal of Chemical Information and Modeling. 61(9). 4745–4757. 14 indexed citations
6.
Bheemanaboina, Rammohan R. Yadav, Alison Roth, Patricia Lee, et al.. (2021). Discovery of Imidazole-Based Inhibitors of Plasmodium falciparum cGMP-Dependent Protein Kinase. ACS Medicinal Chemistry Letters. 12(12). 1962–1967. 5 indexed citations
7.
Childers, Wayne E., Rong Fan, Dennis Colussi, et al.. (2019). Novel compounds that reverse the disease phenotype in Type 2 Gaucher disease patient-derived cells. Bioorganic & Medicinal Chemistry Letters. 30(2). 126806–126806. 5 indexed citations
8.
Colussi, Dennis & Marlene A. Jacobson. (2019). Patient-Derived Phenotypic High-Throughput Assay to Identify Small Molecules Restoring Lysosomal Function in Tay–Sachs Disease. SLAS DISCOVERY. 24(3). 295–303. 11 indexed citations
9.
Stachel, Shawn J., Craig A. Coburn, Kristen L. Jones, et al.. (2009). Discovery of aminoheterocycles as a novel β-secretase inhibitor class: pH dependence on binding activity part 1. Bioorganic & Medicinal Chemistry Letters. 19(11). 2977–2980. 49 indexed citations
10.
Steele, Thomas G., Ivory D. Hills, Timothy J. Allison, et al.. (2008). Identification of a small molecule β-secretase inhibitor that binds without catalytic aspartate engagement. Bioorganic & Medicinal Chemistry Letters. 19(1). 17–20. 17 indexed citations
11.
Barrow, James C., Philippe G. Nantermet, Shaun R. Stauffer, et al.. (2003). Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics. Journal of Medicinal Chemistry. 46(25). 5294–5297. 36 indexed citations
12.
Guertin, Kevin R., Scott I. Klein, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity. Bioorganic & Medicinal Chemistry Letters. 12(12). 1671–1674. 45 indexed citations
13.
He, Wei, Barbara Hanney, Michael R. Myers, et al.. (2002). Benzimidazoles and isosteric compounds as potent and selective factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(6). 919–922. 6 indexed citations
14.
Klein, Scott I., Kevin R. Guertin, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 1: P4 and side-Chain modifications for improved In vitro potency. Bioorganic & Medicinal Chemistry Letters. 12(12). 1667–1670. 14 indexed citations
15.
Gong, Yong, Henry W. Pauls, Alfred P. Spada, et al.. (2000). Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa. Bioorganic & Medicinal Chemistry Letters. 10(3). 217–221. 9 indexed citations
16.
Klein, Scott I., Kevin R. Guertin, Daniel L. Cheney, et al.. (1998). Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa. Journal of Medicinal Chemistry. 41(4). 437–450. 35 indexed citations
17.
Cox, Bryan F., Kenneth L. Clark, Mark H. Perrone, et al.. (1997). Cardiovascular and Metabolic Effects of Adenosine A1-Receptor Agonists in Streptozotocin-Treated Rats. Journal of Cardiovascular Pharmacology. 29(3). 417–426. 17 indexed citations
18.
Merkel, Linda, Eric D. Hawkins, Dennis Colussi, et al.. (1995). Cardiovascular and Antilipolytic Effects of the Adenosine Agonist GR79236. Pharmacology. 51(4). 224–236. 27 indexed citations
19.
Merkel, Linda, et al.. (1993). In vitro and in vivo characterization of an A1-selective adenosine agonist, RG14202.. Journal of Pharmacology and Experimental Therapeutics. 265(2). 699–706. 23 indexed citations
20.
Sioufi, A., et al.. (1984). [Effect of 3 antacids on the bioavailability of pirprofen].. PubMed. 39(1). 23–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Babu Subramanyam Breakdown of academic impact, for papers by Ola Fjellström Breakdown of academic impact, for papers by Massimo Bertinaria Breakdown of academic impact, for papers by Irena Melnikova Breakdown of academic impact, for papers by Robert J. Ife Breakdown of academic impact, for papers by Friederike Stoll Breakdown of academic impact, for papers by Michael Szelke Breakdown of academic impact, for papers by John P. Umland Breakdown of academic impact, for papers by Emanuele Amata Breakdown of academic impact, for papers by Joseph B. Santella
Rankless by CCL
2026